Azithromycin (ophthalmic) dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 11: | Line 11: | ||
====Dosage Forms and Strengths==== | ====Dosage Forms and Strengths==== | ||
2.5 mL of a 1% sterile topical ophthalmic solution. | 2.5 mL of a 1% sterile topical ophthalmic solution.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = |title = AZASITE (AZITHROMYCIN) SOLUTION [INSPIRE PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5dc0f75a-1e14-469f-af4f-c668a32f2328 |publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 21:52, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Dosage And Administration
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days.
Dosage Forms and Strengths
2.5 mL of a 1% sterile topical ophthalmic solution.[1]
References
Adapted from the FDA Package Insert.